Lenzi, A., Lombardo, F., Sgro, P., Salacone, P., Caponecchia, L., Dondero, F., and Gandini, L
Glucagon is classically viewed as a fasting and counter-regulatory hormone that increases hepatic glucose output through glycogenolysis and gluconeogenesis
The Epworth Sleepiness Scale scores improve significantly with consistent CPAP use
If approved for weight management, general eligibility criteria would typically include: Body Mass Index (BMI) 30 kg/m (obesity), or BMI 27 kg/m (overweight) with at least one weight-related comorbidity such as type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea, or cardiovascular disease Age 18 years or older Previous unsuccessful attempts at weight loss through diet and exercise alone Commitment to a comprehensive weight management programme including dietary modification and increased physical activity NICE guidance may specify lower BMI thresholds for certain ethnic groups (particularly those of South Asian origin) who are at increased risk of complications at lower BMI levels
It includes a C-18 fatty acid chain attached to the peptide backbone that enables it to bind to albumin in the blood, extending its half-life to approximately one week